Cargando…

Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study

Various treatment modalities have been practiced for the suppression of premalignant conditions such as oral submucous fibrosis (OSMF) to prevent their differentiation into malignant lesions. Conventional treatment includes steroids, enzymes like hyaluronidase, trypsin, chymotrypsin and placental ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Amit, Kumar, Sanjeev, Srivastava, Pallavi, Rathi, Vidhi C., Saxena, Susmita, Aggarwal, Anju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859608/
https://www.ncbi.nlm.nih.gov/pubmed/35281145
http://dx.doi.org/10.4103/jomfp.JOMFP_192_20
_version_ 1784654500060987392
author Gupta, Amit
Kumar, Sanjeev
Srivastava, Pallavi
Rathi, Vidhi C.
Saxena, Susmita
Aggarwal, Anju
author_facet Gupta, Amit
Kumar, Sanjeev
Srivastava, Pallavi
Rathi, Vidhi C.
Saxena, Susmita
Aggarwal, Anju
author_sort Gupta, Amit
collection PubMed
description Various treatment modalities have been practiced for the suppression of premalignant conditions such as oral submucous fibrosis (OSMF) to prevent their differentiation into malignant lesions. Conventional treatment includes steroids, enzymes like hyaluronidase, trypsin, chymotrypsin and placental extracts which are advocated intralesionally and oral drugs like carotenoids, alpha lipoic acid, lycopene, vitamins, microelements and tea pigments have also been advocated.In this study, a total number of 30 patients with OSMF were taken and randomly divided into two groups with 15 patients each according to Khanna and Andrade group of classification 1995. Group 1 (test group) received the test drug Tretiome 20 mg, whereas Group 2 (control group) received an antioxidant lycopene 20 mg/day for a period of 1 month and the effect of the therapy with the changes in the symptoms was recorded every 1 week, 15 days and 30 days of follow-up. The result of this study showed an improvement in the mouth opening of the patients of test Group with a significant decrease in the burning sensation as compared to the control group (P < 0.05). Xerostomia and headache were the two most commonly seen side effects which were reported in the patients of the test group, of which headache was associated with the withdrawal symptom of habit cessation and xerostomia was taken care by increase in hydration.
format Online
Article
Text
id pubmed-8859608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-88596082022-03-10 Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study Gupta, Amit Kumar, Sanjeev Srivastava, Pallavi Rathi, Vidhi C. Saxena, Susmita Aggarwal, Anju J Oral Maxillofac Pathol Original Article Various treatment modalities have been practiced for the suppression of premalignant conditions such as oral submucous fibrosis (OSMF) to prevent their differentiation into malignant lesions. Conventional treatment includes steroids, enzymes like hyaluronidase, trypsin, chymotrypsin and placental extracts which are advocated intralesionally and oral drugs like carotenoids, alpha lipoic acid, lycopene, vitamins, microelements and tea pigments have also been advocated.In this study, a total number of 30 patients with OSMF were taken and randomly divided into two groups with 15 patients each according to Khanna and Andrade group of classification 1995. Group 1 (test group) received the test drug Tretiome 20 mg, whereas Group 2 (control group) received an antioxidant lycopene 20 mg/day for a period of 1 month and the effect of the therapy with the changes in the symptoms was recorded every 1 week, 15 days and 30 days of follow-up. The result of this study showed an improvement in the mouth opening of the patients of test Group with a significant decrease in the burning sensation as compared to the control group (P < 0.05). Xerostomia and headache were the two most commonly seen side effects which were reported in the patients of the test group, of which headache was associated with the withdrawal symptom of habit cessation and xerostomia was taken care by increase in hydration. Medknow Publications & Media Pvt Ltd 2021 2022-01-11 /pmc/articles/PMC8859608/ /pubmed/35281145 http://dx.doi.org/10.4103/jomfp.JOMFP_192_20 Text en Copyright: © 2022 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gupta, Amit
Kumar, Sanjeev
Srivastava, Pallavi
Rathi, Vidhi C.
Saxena, Susmita
Aggarwal, Anju
Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title_full Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title_fullStr Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title_full_unstemmed Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title_short Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
title_sort effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859608/
https://www.ncbi.nlm.nih.gov/pubmed/35281145
http://dx.doi.org/10.4103/jomfp.JOMFP_192_20
work_keys_str_mv AT guptaamit effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy
AT kumarsanjeev effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy
AT srivastavapallavi effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy
AT rathividhic effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy
AT saxenasusmita effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy
AT aggarwalanju effectoftransretinoicacidonpatientswithoralsubmucousfibrosisrandomizedsingleblindmonocentricstudy